Ani Pharmaceuticals (ANIP) Acquisitions (2018 - 2024)

Ani Pharmaceuticals (ANIP) reported Acquisitions of $8.2 million for Q4 2024, down 90.29% sequentially from $84.5 million in Q4 2021.

Ani Pharmaceuticals (ANIP) Acquisitions (2018 - 2024) Analysis & Trends

Ani Pharmaceuticals (ANIP) has 3 years of Acquisitions data on file, last reported at $8.2 million in Q4 2024.

For the quarter ending Q4 2024, Acquisitions changed N/A year-over-year to $8.2 million; the trailing twelve-month figure through Dec 2025 stood at $8.2 million (changed 0.0% YoY), and the FY2024 full-year result was $401.3 million, changed N/A from the prior year.
Acquisitions eased to $8.2 million in Q4 2024, from $84.5 million in the prior quarter.
In the past five years, Acquisitions ranged from a high of $84.5 million in Q4 2021 to a low of $8.2 million in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	-
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	-
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	-
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	-
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	-
10	Ani Pharmaceuticals	1.64 Bn	1.33 Bn	143.88 Mn	-

Download Data